Study of Telitacicept in Patients With Refractory IgA Nephropathy
Clinical trial NCT05596708 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05596708
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.